2022-2027 Global and Regional Drug Delivery Devices Industry Status and Prospects Professional Market Research Report Standard Version
Date: Jan-2022 | Id: MACRC-74457 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Drug Delivery Devices market was valued at 3624.43 Million USD in 2021 and will grow with a CAGR of 5.08% from 2021 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.By geographical region, the North American market was the largest in 2011. But, the report estimates that by nearly 2018, the share of North America in the drug delivery devices market will slide. The situation in the Asia Pacific will be quite the opposite, as the market in this region will witness accelerated growth on account of rapidly-emerging nations such as China. In the future, China will be an important consumption market of drug delivery systems due to the fast growth of macro economy. With the rising of living standard, people will pay more and more attention on Healthcare, which urges the pharmaceutical companies develop related drugs, drive the development of drug delivery systems market. Briefly speaking, in the next few years, drug delivery devices industry will still be a highly energetic industry. Although sales of drug delivery devices brought a lot of opportunities, the study group recommends the new entrants who just having money but without technical advantage and downstream support, do not to enter into the drug delivery devices field hastily. By Market Verdors: Cipla Baxter International Nipro Corporation Roche Boehringer Ingelheim Allergan 3M BD Catalent Bausch Health Bayer AG Chiesi Phillips-Medisize Johnson & Johnson Shandong Weigao Pfizer B.Braun Novartis AG Zhengkang Gerresheimer COVIDIEN Medtronic Schott forma vitrum Alkermes Skyepharma By Types: Injection type Mucosal type Implanted type By Applications: Pharmaceutical companies Hospitals Clinics Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview 1.1 Definition 1.2 Assumptions 1.3 Research Scope 1.4 Market Analysis by Regions 1.4.1 North America Market States and Outlook (2022-2027) 1.4.2 East Asia Market States and Outlook (2022-2027) 1.4.3 Europe Market States and Outlook (2022-2027) 1.4.4 South Asia Market States and Outlook (2022-2027) 1.4.5 Southeast Asia Market States and Outlook (2022-2027) 1.4.6 Middle East Market States and Outlook (2022-2027) 1.4.7 Africa Market States and Outlook (2022-2027) 1.4.8 Oceania Market States and Outlook (2022-2027) 1.4.9 South America Market States and Outlook (2022-2027) 1.5 Global Drug Delivery Devices Market Size Analysis from 2022 to 2027 1.5.1 Global Drug Delivery Devices Market Size Analysis from 2022 to 2027 by Consumption Volume 1.5.2 Global Drug Delivery Devices Market Size Analysis from 2022 to 2027 by Value 1.5.3 Global Drug Delivery Devices Price Trends Analysis from 2022 to 2027 1.6 COVID-19 Outbreak: Drug Delivery Devices Industry Impact Chapter 2 Global Drug Delivery Devices Competition by Types, Applications, and Top Regions and Countries 2.1 Global Drug Delivery Devices (Volume and Value) by Type 2.1.1 Global Drug Delivery Devices Consumption and Market Share by Type (2016-2021) 2.1.2 Global Drug Delivery Devices Revenue and Market Share by Type (2016-2021) 2.2 Global Drug Delivery Devices (Volume and Value) by Application 2.2.1 Global Drug Delivery Devices Consumption and Market Share by Application (2016-2021) 2.2.2 Global Drug Delivery Devices Revenue and Market Share by Application (2016-2021) 2.3 Global Drug Delivery Devices (Volume and Value) by Regions 2.3.1 Global Drug Delivery Devices Consumption and Market Share by Regions (2016-2021) 2.3.2 Global Drug Delivery Devices Revenue and Market Share by Regions (2016-2021) Chapter 3 Production Market Analysis 3.1 Global Production Market Analysis 3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis 3.1.2 2016-2021 Major Manufacturers Performance and Market Share 3.2 Regional Production Market Analysis 3.2.1 2016-2021 Regional Market Performance and Market Share 3.2.2 North America Market 3.2.3 East Asia Market 3.2.4 Europe Market 3.2.5 South Asia Market 3.2.6 Southeast Asia Market 3.2.7 Middle East Market 3.2.8 Africa Market 3.2.9 Oceania Market 3.2.10 South America Market 3.2.11 Rest of the World Market Chapter 4 Global Drug Delivery Devices Sales, Consumption, Export, Import by Regions (2016-2021) 4.1 Global Drug Delivery Devices Consumption by Regions (2016-2021) 4.2 North America Drug Delivery Devices Sales, Consumption, Export, Import (2016-2021) 4.3 East Asia Drug Delivery Devices Sales, Consumption, Export, Import (2016-2021) 4.4 Europe Drug Delivery Devices Sales, Consumption, Export, Import (2016-2021) 4.5 South Asia Drug Delivery Devices Sales, Consumption, Export, Import (2016-2021) 4.6 Southeast Asia Drug Delivery Devices Sales, Consumption, Export, Import (2016-2021) 4.7 Middle East Drug Delivery Devices Sales, Consumption, Export, Import (2016-2021) 4.8 Africa Drug Delivery Devices Sales, Consumption, Export, Import (2016-2021) 4.9 Oceania Drug Delivery Devices Sales, Consumption, Export, Import (2016-2021) 4.10 South America Drug Delivery Devices Sales, Consumption, Export, Import (2016-2021) Chapter 5 North America Drug Delivery Devices Market Analysis 5.1 North America Drug Delivery Devices Consumption and Value Analysis 5.1.1 North America Drug Delivery Devices Market Under COVID-19 5.2 North America Drug Delivery Devices Consumption Volume by Types 5.3 North America Drug Delivery Devices Consumption Structure by Application 5.4 North America Drug Delivery Devices Consumption by Top Countries 5.4.1 United States Drug Delivery Devices Consumption Volume from 2016 to 2021 5.4.2 Canada Drug Delivery Devices Consumption Volume from 2016 to 2021 5.4.3 Mexico Drug Delivery Devices Consumption Volume from 2016 to 2021 Chapter 6 East Asia Drug Delivery Devices Market Analysis 6.1 East Asia Drug Delivery Devices Consumption and Value Analysis 6.1.1 East Asia Drug Delivery Devices Market Under COVID-19 6.2 East Asia Drug Delivery Devices Consumption Volume by Types 6.3 East Asia Drug Delivery Devices Consumption Structure by Application 6.4 East Asia Drug Delivery Devices Consumption by Top Countries 6.4.1 China Drug Delivery Devices Consumption Volume from 2016 to 2021 6.4.2 Japan Drug Delivery Devices Consumption Volume from 2016 to 2021 6.4.3 South Korea Drug Delivery Devices Consumption Volume from 2016 to 2021 Chapter 7 Europe Drug Delivery Devices Market Analysis 7.1 Europe Drug Delivery Devices Consumption and Value Analysis 7.1.1 Europe Drug Delivery Devices Market Under COVID-19 7.2 Europe Drug Delivery Devices Consumption Volume by Types 7.3 Europe Drug Delivery Devices Consumption Structure by Application 7.4 Europe Drug Delivery Devices Consumption by Top Countries 7.4.1 Germany Drug Delivery Devices Consumption Volume from 2016 to 2021 7.4.2 UK Drug Delivery Devices Consumption Volume from 2016 to 2021 7.4.3 France Drug Delivery Devices Consumption Volume from 2016 to 2021 7.4.4 Italy Drug Delivery Devices Consumption Volume from 2016 to 2021 7.4.5 Russia Drug Delivery Devices Consumption Volume from 2016 to 2021 7.4.6 Spain Drug Delivery Devices Consumption Volume from 2016 to 2021 7.4.7 Netherlands Drug Delivery Devices Consumption Volume from 2016 to 2021 7.4.8 Switzerland Drug Delivery Devices Consumption Volume from 2016 to 2021 7.4.9 Poland Drug Delivery Devices Consumption Volume from 2016 to 2021 Chapter 8 South Asia Drug Delivery Devices Market Analysis 8.1 South Asia Drug Delivery Devices Consumption and Value Analysis 8.1.1 South Asia Drug Delivery Devices Market Under COVID-19 8.2 South Asia Drug Delivery Devices Consumption Volume by Types 8.3 South Asia Drug Delivery Devices Consumption Structure by Application 8.4 South Asia Drug Delivery Devices Consumption by Top Countries 8.4.1 India Drug Delivery Devices Consumption Volume from 2016 to 2021 8.4.2 Pakistan Drug Delivery Devices Consumption Volume from 2016 to 2021 8.4.3 Bangladesh Drug Delivery Devices Consumption Volume from 2016 to 2021 Chapter 9 Southeast Asia Drug Delivery Devices Market Analysis 9.1 Southeast Asia Drug Delivery Devices Consumption and Value Analysis 9.1.1 Southeast Asia Drug Delivery Devices Market Under COVID-19 9.2 Southeast Asia Drug Delivery Devices Consumption Volume by Types 9.3 Southeast Asia Drug Delivery Devices Consumption Structure by Application 9.4 Southeast Asia Drug Delivery Devices Consumption by Top Countries 9.4.1 Indonesia Drug Delivery Devices Consumption Volume from 2016 to 2021 9.4.2 Thailand Drug Delivery Devices Consumption Volume from 2016 to 2021 9.4.3 Singapore Drug Delivery Devices Consumption Volume from 2016 to 2021 9.4.4 Malaysia Drug Delivery Devices Consumption Volume from 2016 to 2021 9.4.5 Philippines Drug Delivery Devices Consumption Volume from 2016 to 2021 9.4.6 Vietnam Drug Delivery Devices Consumption Volume from 2016 to 2021 9.4.7 Myanmar Drug Delivery Devices Consumption Volume from 2016 to 2021 Chapter 10 Middle East Drug Delivery Devices Market Analysis 10.1 Middle East Drug Delivery Devices Consumption and Value Analysis 10.1.1 Middle East Drug Delivery Devices Market Under COVID-19 10.2 Middle East Drug Delivery Devices Consumption Volume by Types 10.3 Middle East Drug Delivery Devices Consumption Structure by Application 10.4 Middle East Drug Delivery Devices Consumption by Top Countries 10.4.1 Turkey Drug Delivery Devices Consumption Volume from 2016 to 2021 10.4.2 Saudi Arabia Drug Delivery Devices Consumption Volume from 2016 to 2021 10.4.3 Iran Drug Delivery Devices Consumption Volume from 2016 to 2021 10.4.4 United Arab Emirates Drug Delivery Devices Consumption Volume from 2016 to 2021 10.4.5 Israel Drug Delivery Devices Consumption Volume from 2016 to 2021 10.4.6 Iraq Drug Delivery Devices Consumption Volume from 2016 to 2021 10.4.7 Qatar Drug Delivery Devices Consumption Volume from 2016 to 2021 10.4.8 Kuwait Drug Delivery Devices Consumption Volume from 2016 to 2021 10.4.9 Oman Drug Delivery Devices Consumption Volume from 2016 to 2021 Chapter 11 Africa Drug Delivery Devices Market Analysis 11.1 Africa Drug Delivery Devices Consumption and Value Analysis 11.1.1 Africa Drug Delivery Devices Market Under COVID-19 11.2 Africa Drug Delivery Devices Consumption Volume by Types 11.3 Africa Drug Delivery Devices Consumption Structure by Application 11.4 Africa Drug Delivery Devices Consumption by Top Countries 11.4.1 Nigeria Drug Delivery Devices Consumption Volume from 2016 to 2021 11.4.2 South Africa Drug Delivery Devices Consumption Volume from 2016 to 2021 11.4.3 Egypt Drug Delivery Devices Consumption Volume from 2016 to 2021 11.4.4 Algeria Drug Delivery Devices Consumption Volume from 2016 to 2021 11.4.5 Morocco Drug Delivery Devices Consumption Volume from 2016 to 2021 Chapter 12 Oceania Drug Delivery Devices Market Analysis 12.1 Oceania Drug Delivery Devices Consumption and Value Analysis 12.2 Oceania Drug Delivery Devices Consumption Volume by Types 12.3 Oceania Drug Delivery Devices Consumption Structure by Application 12.4 Oceania Drug Delivery Devices Consumption by Top Countries 12.4.1 Australia Drug Delivery Devices Consumption Volume from 2016 to 2021 12.4.2 New Zealand Drug Delivery Devices Consumption Volume from 2016 to 2021 Chapter 13 South America Drug Delivery Devices Market Analysis 13.1 South America Drug Delivery Devices Consumption and Value Analysis 13.1.1 South America Drug Delivery Devices Market Under COVID-19 13.2 South America Drug Delivery Devices Consumption Volume by Types 13.3 South America Drug Delivery Devices Consumption Structure by Application 13.4 South America Drug Delivery Devices Consumption Volume by Major Countries 13.4.1 Brazil Drug Delivery Devices Consumption Volume from 2016 to 2021 13.4.2 Argentina Drug Delivery Devices Consumption Volume from 2016 to 2021 13.4.3 Columbia Drug Delivery Devices Consumption Volume from 2016 to 2021 13.4.4 Chile Drug Delivery Devices Consumption Volume from 2016 to 2021 13.4.5 Venezuela Drug Delivery Devices Consumption Volume from 2016 to 2021 13.4.6 Peru Drug Delivery Devices Consumption Volume from 2016 to 2021 13.4.7 Puerto Rico Drug Delivery Devices Consumption Volume from 2016 to 2021 13.4.8 Ecuador Drug Delivery Devices Consumption Volume from 2016 to 2021 Chapter 14 Company Profiles and Key Figures in Drug Delivery Devices Business 14.1 Cipla 14.1.1 Cipla Company Profile 14.1.2 Cipla Drug Delivery Devices Product Specification 14.1.3 Cipla Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.2 Baxter International 14.2.1 Baxter International Company Profile 14.2.2 Baxter International Drug Delivery Devices Product Specification 14.2.3 Baxter International Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.3 Nipro Corporation 14.3.1 Nipro Corporation Company Profile 14.3.2 Nipro Corporation Drug Delivery Devices Product Specification 14.3.3 Nipro Corporation Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.4 Roche 14.4.1 Roche Company Profile 14.4.2 Roche Drug Delivery Devices Product Specification 14.4.3 Roche Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.5 Boehringer Ingelheim 14.5.1 Boehringer Ingelheim Company Profile 14.5.2 Boehringer Ingelheim Drug Delivery Devices Product Specification 14.5.3 Boehringer Ingelheim Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.6 Allergan 14.6.1 Allergan Company Profile 14.6.2 Allergan Drug Delivery Devices Product Specification 14.6.3 Allergan Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.7 3M 14.7.1 3M Company Profile 14.7.2 3M Drug Delivery Devices Product Specification 14.7.3 3M Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.8 BD 14.8.1 BD Company Profile 14.8.2 BD Drug Delivery Devices Product Specification 14.8.3 BD Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.9 Catalent 14.9.1 Catalent Company Profile 14.9.2 Catalent Drug Delivery Devices Product Specification 14.9.3 Catalent Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.10 Bausch Health 14.10.1 Bausch Health Company Profile 14.10.2 Bausch Health Drug Delivery Devices Product Specification 14.10.3 Bausch Health Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.11 Bayer AG 14.11.1 Bayer AG Company Profile 14.11.2 Bayer AG Drug Delivery Devices Product Specification 14.11.3 Bayer AG Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.12 Chiesi 14.12.1 Chiesi Company Profile 14.12.2 Chiesi Drug Delivery Devices Product Specification 14.12.3 Chiesi Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.13 Phillips-Medisize 14.13.1 Phillips-Medisize Company Profile 14.13.2 Phillips-Medisize Drug Delivery Devices Product Specification 14.13.3 Phillips-Medisize Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.14 Johnson & Johnson 14.14.1 Johnson & Johnson Company Profile 14.14.2 Johnson & Johnson Drug Delivery Devices Product Specification 14.14.3 Johnson & Johnson Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.15 Shandong Weigao 14.15.1 Shandong Weigao Company Profile 14.15.2 Shandong Weigao Drug Delivery Devices Product Specification 14.15.3 Shandong Weigao Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.16 Pfizer 14.16.1 Pfizer Company Profile 14.16.2 Pfizer Drug Delivery Devices Product Specification 14.16.3 Pfizer Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.17 B.Braun 14.17.1 B.Braun Company Profile 14.17.2 B.Braun Drug Delivery Devices Product Specification 14.17.3 B.Braun Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.18 Novartis AG 14.18.1 Novartis AG Company Profile 14.18.2 Novartis AG Drug Delivery Devices Product Specification 14.18.3 Novartis AG Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.19 Zhengkang 14.19.1 Zhengkang Company Profile 14.19.2 Zhengkang Drug Delivery Devices Product Specification 14.19.3 Zhengkang Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.20 Gerresheimer 14.20.1 Gerresheimer Company Profile 14.20.2 Gerresheimer Drug Delivery Devices Product Specification 14.20.3 Gerresheimer Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.21 COVIDIEN Medtronic 14.21.1 COVIDIEN Medtronic Company Profile 14.21.2 COVIDIEN Medtronic Drug Delivery Devices Product Specification 14.21.3 COVIDIEN Medtronic Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.22 Schott forma vitrum 14.22.1 Schott forma vitrum Company Profile 14.22.2 Schott forma vitrum Drug Delivery Devices Product Specification 14.22.3 Schott forma vitrum Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.23 Alkermes 14.23.1 Alkermes Company Profile 14.23.2 Alkermes Drug Delivery Devices Product Specification 14.23.3 Alkermes Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.24 Skyepharma 14.24.1 Skyepharma Company Profile 14.24.2 Skyepharma Drug Delivery Devices Product Specification 14.24.3 Skyepharma Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) Chapter 15 Global Drug Delivery Devices Market Forecast (2022-2027) 15.1 Global Drug Delivery Devices Consumption Volume, Revenue and Price Forecast (2022-2027) 15.1.1 Global Drug Delivery Devices Consumption Volume and Growth Rate Forecast (2022-2027) 15.1.2 Global Drug Delivery Devices Value and Growth Rate Forecast (2022-2027) 15.2 Global Drug Delivery Devices Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027) 15.2.1 Global Drug Delivery Devices Consumption Volume and Growth Rate Forecast by Regions (2022-2027) 15.2.2 Global Drug Delivery Devices Value and Growth Rate Forecast by Regions (2022-2027) 15.2.3 North America Drug Delivery Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.4 East Asia Drug Delivery Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.5 Europe Drug Delivery Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.6 South Asia Drug Delivery Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.7 Southeast Asia Drug Delivery Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.8 Middle East Drug Delivery Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.9 Africa Drug Delivery Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.10 Oceania Drug Delivery Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.11 South America Drug Delivery Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.3 Global Drug Delivery Devices Consumption Volume, Revenue and Price Forecast by Type (2022-2027) 15.3.1 Global Drug Delivery Devices Consumption Forecast by Type (2022-2027) 15.3.2 Global Drug Delivery Devices Revenue Forecast by Type (2022-2027) 15.3.3 Global Drug Delivery Devices Price Forecast by Type (2022-2027) 15.4 Global Drug Delivery Devices Consumption Volume Forecast by Application (2022-2027) 15.5 Drug Delivery Devices Market Forecast Under COVID-19 Chapter 16 Conclusions Research Methodology
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000